A preliminary study found that people receiving immunotherapy for lung cancer or melanoma lived longer if they had received ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells—an advance ...

Some cancer patients at The University of Texas MD Anderson Cancer Center got an unexpected boost. After receiving the ...

MIT and Broad Institute researchers have developed an mRNA approach that temporarily programs liver cells to produce ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that ...

SMRTS, a smart mRNA system, enables cell‑selective gene expression, expanding the mRNA toolbox for precision cancer therapies.

Can the weakened immune systems of older individuals be rejuvenated? Researchers from the German Cancer Research Center (DKFZ ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells-an advance ...

No matter where cancer cells grow in the human body, they are a threat to our health and our lives. But instead of treating ...

A therapy based on messenger RNA (mRNA), a genetic material actively studied for vaccines and other applications, has turned ...

Testing in mice suggests that rejuvenating T cells could make vaccines and some cancer therapies more effective.